Translyx
Product portfolio

Authorised partner solutions and Privexa-built protected AI, under one accountable partner.

Aiforia digital pathology AI, Privexa-built protected software, and a clinical diagnostic pipeline — clinically positioned and locally supported by Translyx across New Zealand and Oceania.

Built by Privexa

Protected AI software

Privacy-first, governed, and reviewer-gated software clinically positioned through Translyx.

Diagnostic portfolio

Clinical & Diagnostic Pipeline

AMR, sepsis, point-of-care testing, oncology, endocrine, cardiac, and precision medicine opportunities for New Zealand and Oceania.

View pipeline
Product ecosystem

One company. A governed bridge between global innovation and local clinical adoption.

Translyx connects authorised digital pathology AI, Privexa-built protected software, and a clinical diagnostic pipeline — under one accountable, New Zealand-based partner.

Clinical technology partner

Translyx Limited

Auckland, New Zealand · Oceania

Aiforia is an authorised partner solution represented by Translyx in New Zealand — not a Translyx-owned product. Privexa-built products are developed by Privexa Limited and clinically positioned through Translyx.

Speak with Translyx about your clinical technology priorities.

Request a walkthrough to see Aiforia digital pathology AI, Privexa-built protected software, and the broader diagnostic portfolio in context.